Acquired hemophilia A: Updated review of evidence and treatment guidance
Top Cited Papers
- 5 June 2017
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 92 (7), 695-705
- https://doi.org/10.1002/ajh.24777
Abstract
Acquired hemophilia A (AHA) is a rare disease resulting from autoantibodies (inhibitors) against endogenous factor VIII (FVIII) that leads to bleeding, which is often spontaneous and severe. AHA tends to occur in elderly patients with comorbidities and is associated with high mortality risk from underlying comorbidities, bleeding, or treatment complications. Treatment, which consists of hemostatic management and eradication of the inhibitors, can be challenging to manage. Few data are available to guide the management of AHA-related bleeding and eradication of the disease-causing antibodies. Endorsed by the Hemostasis and Thrombosis Research Society of North America, an international panel of experts in AHA analyzed key questions, reviewed the literature, weighed the evidence and formed a consensus to update existing guidelines. AHA is likely underdiagnosed and misdiagnosed in real-world clinical practice. Recommendations for the management of AHA are summarized here based on the available data, integrated with the clinical experience of panel participants.Keywords
Funding Information
- Baxter Healthcare Corporation
This publication has 56 references indexed in Scilit:
- A study of 65 patients with acquired hemophilia A in TaiwanJournal of the Formosan Medical Association, 2015
- Pregnancy‐associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registryBJOG: An International Journal of Obstetrics and Gynaecology, 2012
- Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)Blood, 2012
- Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A – a two‐centre experienceHaemophilia, 2012
- Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)Journal of Thrombosis and Haemostasis, 2012
- Guidelines on the investigation and management of antiphospholipid syndromeBritish Journal of Haematology, 2012
- International recommendations on the diagnosis and treatment of patients with acquired hemophilia AHaematologica, 2009
- Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophiliaHaemophilia, 2008
- Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia AJournal of Thrombosis and Haemostasis, 2007
- Cyclosporin treatment of a woman with acquired haemophilia due to factor VIII:C inhibitorPublished by Oxford University Press (OUP) ,1989